ArticleJournal of fluorescence2026
A Simple Fluorescent Aptasensing Setup Controlled by Hybridization Chain Reaction for Detection of Illegal Drug Methamphetamine: A Future Point-of-Care Testing Assay.
Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In this study, a simple and sensitive label-free fluorescent assay was developed for the detection of methamphetamine (MET) by utilizing a hybridization chain reaction (HCR) product as a signal amplifier. This strategy utilizes berberine (BER) as a fluorescent dye, serving as a molecular marker. The detection strategy is based on the disassembly of the HCR product resulting from the interaction of the aptamer with MET, which releases multiple single-stranded DNA (ssDNA) sequences. The fluorescent signal is significantly enhanced through the intercalation of BER into ssDNA regions. The linear concentration range for MET detection was achieved from 1 nM to 150 µM with a limit of detection (LOD) of 0.28 nM. Moreover, the sensor exhibited an excellent sensitivity and selectivity for MET detection in the complex biological matrices, including artificial tear fluid, saliva, and human serum. The notable sensitivity, simplicity, and robustness of this aptasensor indicate its significant potential for applications in doping control and detection of prohibited substances in sports.
Indexed as
Identifiers
42501200What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.